Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$294.76M$294.76Mderived+3.8% vs Q4 2023 Net Income$43.24M$43.24Mderived+34.9% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Cash Flowderived$57,573,000+8.2% Free Cash Flowderived-$53,266,000— Margins · derivedNet margin14.7%+3.4 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 25, 2025 · 56 d after period end